Clinical Trial Update: Study of XL281 in Adults With Solid Tumors [Phase 1]

View source ↗

Summary

Exelixis reports completion of a Phase 1 study of XL281 in adults with solid tumors, including non-small cell lung cancer, colorectal cancer, papillary thyroid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Melanoma
• Non-small Cell Lung Cancer
• Papillary Thyroid Cancer

Drugs mentioned

• XL281

Snippet

Sponsor: Exelixis | Conditions: Cancer, Non-small-cell Lung Cancer | Phase 1 | Status: COMPLETED